Results 141 to 150 of about 58,542 (264)

Plaque‐type trichoblastoma and its siblings: A (follicular tumour) family history

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ines Bertlich   +4 more
wiley   +1 more source

Beyond Deterministic Fetal Programming: Intrauterine Exposures and the Multifactorial Origins of Adiposity

open access: yesObesity Reviews, EarlyView.
ABSTRACT Excess adiposity is not a recently developed problem but has existed since at least the upper Paleolithic, allowing evolutionary selection pressures to adapt the physiology of the pregnant woman and the feto‐placental unit for maternal and fetal protection.
Gernot Desoye   +6 more
wiley   +1 more source

Sonidegib efficacy and safety in ultra‐nonagenarian patients

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Camilla Brunello   +5 more
wiley   +1 more source

Thymoquinone mediated hedgehog pathway activation and gut microbiota modulation in mouse colitis. [PDF]

open access: yesSci Rep
Huang X   +9 more
europepmc   +1 more source

Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2023
Banaszek N   +4 more
europepmc   +1 more source

Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective This study aimed to investigate gene mutations in ameloblastic carcinoma (AC) including BRAF, KRAS, and PIK3CA, along with associated protein expressions of BRAF V600E, p‐ERK1/2, and p‐mTOR, which represent activation of MAPK/ERK and PI3K/mTOR pathways, respectively.
Puangwan Lapthanasupkul   +4 more
wiley   +1 more source

Setmelanotide in Bardet‐Biedl Syndrome: A Case Report

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication.
Shelby Smith   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy